Stout Jay S — SEC Form 4 filings
SEC reporting owner CIK 1702969. 20 Form 4 filings on record with FilingPulse; latest filed 2026-07-24.
Transaction summary — filings shown
Covers all 20 filings on record, filed 2024-04-04 to 2026-07-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 23 legs across 17 filings — 92,755 shares, $2,861,648 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 6.
- Largest priced transaction: sale of 33,277 shares @ $38.18 ($1,270,516) in Immunovant, Inc., filed 2026-06-26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Immunovant, Inc. (IMVT) | Chief Technology Officer | 20 | — | 23 legs · 92,755 sh · $2,861,648 | 6 |
Form 4 filings — Stout Jay S
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-24 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 2,857 @ $38.69 | EDGAR |
| 2026-07-10 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 1,906 @ $39.53 · Sale (S): 105 @ $39.99 · Sale (S): 1,399 @ $39.53 · Sale (S): 77 @ $39.99 | EDGAR |
| 2026-06-26 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 33,277 @ $38.18 · Sale (S): 6,723 @ $38.94 | EDGAR |
| 2026-04-24 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 2,754 @ $29.62 | EDGAR |
| 2026-04-10 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 8,614 @ $24.83 · Sale (S): 1,518 @ $24.83 | EDGAR |
| 2026-04-09 | 4 | Immunovant, Inc. (IMVT) | Grant/award (A): 66,937 @ $0 · Grant/award (A): 96,851 (derivative) @ $0 | EDGAR |
| 2026-01-23 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 1,977 @ $26.03 | EDGAR |
| 2026-01-09 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 1,148 @ $26.51 · Sale (S): 55 @ $26.92 | EDGAR |
| 2025-10-24 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 2,520 @ $19.03 | EDGAR |
| 2025-10-10 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 1,585 @ $16.30 | EDGAR |
| 2025-07-25 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 2,805 @ $18.15 | EDGAR |
| 2025-07-11 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 1,519 @ $17.24 | EDGAR |
| 2025-04-25 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 1,925 @ $14.79 | EDGAR |
| 2025-04-11 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 5,004 @ $12.99 | EDGAR |
| 2025-04-03 | 4 | Immunovant, Inc. (IMVT) | Grant/award (A): 76,181 @ $0 · Grant/award (A): 107,297 (derivative) @ $0 | EDGAR |
| 2025-01-24 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 2,195 @ $23.59 | EDGAR |
| 2024-10-25 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 2,740 @ $29.53 | EDGAR |
| 2024-07-26 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 2,813 @ $27.76 | EDGAR |
| 2024-04-26 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 7,239 @ $28.90 | EDGAR |
| 2024-04-04 | 4 | Immunovant, Inc. (IMVT) | Grant/award (A): 54,978 @ $0 · Grant/award (A): 68,723 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1702969 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →